Researchers develop new ‘raspberry-shaped’ nanoparticle for precision drug delivery
A newly discovered technique, reported in the journal Nanoscale, offers a low-cost way to enhance the effectiveness of existing drugs.
Read moreUnderstanding soundscapes in day cares can pave the way toward better child care
During some of their most formative years, many children go to day care centers outside their homes. While there, they
Read moreVolatile pay for gig workers linked to health problems
Gig workers, waiters, salespeople and others who rely on fluctuating income may be paying for wage volatility with their health,
Read moreAntibodies against gentamicin associated with increased risk of type 1 diabetes in children
Antibodies produced against the commonly used antibiotic, gentamicin, appear to increase the risk of type 1 diabetes in children already
Read moreNew research urges governments to invest in healthcare digitization
Photo: Philips The Partnership for Health System Sustainability and Resilience, or PHSSR, a collaboration between academia, non-governmental life sciences and
Read moreExperts find certain vitamin linked to ‘less cognitive decline’
John Lydon describes his wife's battle with Alzheimer's We use your sign-up to provide content in ways you’ve consented to
Read moreRoutine Cancer Screenings Still Below Prepandemic Levels
Cancer screenings for breast, cervical, and colorectal cancer remain below prepandemic levels, having never fully bounced back after the initial sharp
Read moreDiscovery of ’raspberry-shaped’ nanoparticle offers a way to enhance the effectiveness of existing drugs
A newly discovered technique, reported in the journal Nanoscale, offers a low-cost way to enhance the effectiveness of existing drugs.
Read moreNew receptor ‘decoy’ drug neutralizes COVID-19 virus and its variants
Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective
Read moreT-DXd yields superior outcomes over chemotherapy-based regimens in patients previously treated with T-DM1
Compared with capecitabine-based regimens, trastuzumab deruxtecan (T-DXd) led to higher response rates and longer survival in the third-line setting for
Read more